Okay, now that we have given you Venom Hyperdrive 3.0™ (you know the mega-energy-rapid calorie expenditure phenomenon) and Venom Lean Dreams™ (sleep/relaxation and healthy GH modulator…because you can’t stay wired 24/7) it is time to introduce the final key to the Venom Series appropriately called…Venom Special Tactics™.

Venom Special Tactics™ is The highest standard by which all other stimulant free adipose inhibition and oxidation products should be measured by. (As in…it inhibits fat storage and aids burning the flab too) This new only from ALR Industries product makes your body burn fat by wasting calories at an accelerated rate while protecting lean tissue mass and supporting thyroid health….even while you are sitting on your butt! (Imagine adding the Venom Series training and diet system!) Venom Special Tactics™ can be used alone, or stacked with the rest of the Venom Series and TX™ for Super Charged “I want it today” results.

What makes this One Different from the Other ALR Industries Venom™ Products?

Hey, it’s from ALR Industries. You already know the innovation and results will piss some wanna-be scientist off because it is new, it works and they don’t understand it.

Theobroma Cacao extract for 12% OEA (oleoylethanolamide) and 3-Thia-Palmitic Acid (Tetradecylthioacetic acid) are very cool compounds that promote lipolysis (blubber burning) through some unique pathways.

OEA is produced in the small intestine and belongs to a group of fats produced in response to nervous system activity and certain metabolic events.

In an interesting mammal study published in the Journal of Biological Chemistry, OEA was shown to reduce feeding and body weight gain by activating the nuclear receptor PPAR-alpha (peroxisome proliferator-activated receptor alpha). In the present report, we examined whether OEA can also influence energy utilization. OEA stimulated glycerol and fatty acid release from freshly dissociated rat adipocytes. OEA enhanced fatty acid oxidation in skeletal muscle strips, dissociated hepatocytes, and primary cardiomyocyte cultures. Administration of OEA in vivo produced lipolysis.

In short, the OEA study results showed a decrease in food intake and an increase in calorie expenditure by way of lipolysis and fat oxidation through a unique pathway. The same study left us with this quote to consider: “The results suggest that OEA stimulates fat utilization through activation of PPAR-alpha and that this effect may contribute to its anti-obesity actions”.

***These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, or prevent any disease.***